- Home
- ZCAR vs LGVN Comparison
ZCAR vs LGVN Comparison
Compare ZCAR & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCAR
- LGVN
- Stock Information
- Founded
- ZCAR 2013
- LGVN 2014
- Country
- ZCAR India
- LGVN United States
- Employees
- ZCAR N/A
- LGVN N/A
- Industry
- ZCAR Blank Checks
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- ZCAR Finance
- LGVN Health Care
- Exchange
- ZCAR Nasdaq
- LGVN Nasdaq
- Market Cap
- ZCAR 10.7M
- LGVN 30.0M
- IPO Year
- ZCAR N/A
- LGVN 2021
- Fundamental
- Price
- ZCAR $6.14
- LGVN $2.05
- Analyst Decision
- ZCAR
- LGVN Strong Buy
- Analyst Count
- ZCAR 0
- LGVN 2
- Target Price
- ZCAR N/A
- LGVN $8.00
- AVG Volume (30 Days)
- ZCAR 1.1M
- LGVN 393.9K
- Earning Date
- ZCAR 11-15-2024
- LGVN 11-08-2024
- Dividend Yield
- ZCAR N/A
- LGVN N/A
- EPS Growth
- ZCAR N/A
- LGVN N/A
- EPS
- ZCAR N/A
- LGVN N/A
- Revenue
- ZCAR $9,523,600.00
- LGVN $1,229,000.00
- Revenue This Year
- ZCAR N/A
- LGVN $161.78
- Revenue Next Year
- ZCAR N/A
- LGVN $8.62
- P/E Ratio
- ZCAR N/A
- LGVN N/A
- Revenue Growth
- ZCAR N/A
- LGVN 39.34
- 52 Week Low
- ZCAR $5.72
- LGVN $0.77
- 52 Week High
- ZCAR $761.00
- LGVN $23.90
- Technical
- Relative Strength Index (RSI)
- ZCAR 19.46
- LGVN 52.20
- Support Level
- ZCAR $0.13
- LGVN $1.76
- Resistance Level
- ZCAR $0.15
- LGVN $2.26
- Average True Range (ATR)
- ZCAR 0.01
- LGVN 0.12
- MACD
- ZCAR -0.01
- LGVN 0.05
- Stochastic Oscillator
- ZCAR 12.00
- LGVN 58.00
About ZCAR Zoomcar Holdings Inc.
Zoomcar Holdings Inc is India's largest marketplace for cars on rent. Zoomcar is a leading emerging-market-focused peer-to-peer car-sharing marketplace, with approximately 21,000 vehicles registered through its platform. The Company derives its revenue principally from short-term self-drive rentals and vehicle subscriptions. The self-drive rental business generates the majority of revenue. Geographically The company operates in India, Egypt, Indonesia, Vietnam, and the Philippines, Out of which the majority of revenue is derived from India.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.